Brain Quinolinic Acid in Huntington's Disease
- 31 May 1988
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 50 (6), 1959-1968
- https://doi.org/10.1111/j.1471-4159.1988.tb02503.x
Abstract
Concentrations of the endogenous neurotoxic tryptophan metabolite, quinolinic acid (QA), were measured in postmortem brain tissue obtained from patients with Huntington''s disease (HD) and matched controls, using a gas chromatography/mass spectrometry method. There was no significant difference in either the putamen or the frontal cortex between the HD and control groups. These results do not support the hypothesis that increased QA is responsible for neuronal degeneration in HD.Keywords
This publication has 8 references indexed in Scilit:
- No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acidNature, 1987
- Tissue culture evidence for a circulating neurotoxin in Huntington's choreaJournal of the Neurological Sciences, 1987
- Senile Dementia and Alzheimer's disease: Lack of changes of the cortical content of Quinolinic AcidNeurobiology of Aging, 1986
- Replication of the neurochemical characteristics of Huntington's disease by quinolinic acidNature, 1986
- Normal excretion of quinolinic acid in Huntington's diseaseLife Sciences, 1985
- The excitotoxin quinolinic acid is present and unevenly distributed in the rat brainBrain Research, 1984
- Identification of quinolinic acid in rat and human brain tissueNeuroscience Letters, 1983
- AN ANALYSIS OF FACTORS INFLUENCING MEASUREMENTS OF DOPAMINE, NORADRENALINE, GLUTAMATEDECARBOXYLASE AND CHOLINE ACETYLASE IN HUMAN POST-MORTEM BRAIN TISSUEBrain, 1979